Bonus Issues

LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE425.30-9.1 (-2.09 %)
PREV CLOSE ( ) 434.40
OPEN PRICE ( ) 432.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 191193
TODAY'S LOW / HIGH ( )420.20 438.30
52 WK LOW / HIGH ( )279.65 470.9
NSE425.90-8.5 (-1.96 %)
PREV CLOSE( ) 434.40
OPEN PRICE ( ) 434.45
BID PRICE (QTY) 425.90 (79)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3421872
TODAY'S LOW / HIGH( ) 420.05 438.90
52 WK LOW / HIGH ( )278.85 471

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.